Clinical Trial Update: A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) [Phase 3]

View source ↗

Summary

A Phase 3 randomized study investigating azetukalner versus placebo for major depressive disorder is currently recruiting (X-NOVA3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Azetukalner

Snippet

Sponsor: Xenon Pharmaceuticals Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: RECRUITING